Literature DB >> 3783449

Influence of intravenous infusion duration on the tissue drug concentration profile.

D A Uccellini, K Raymond, D J Morgan.   

Abstract

The influence of intravenous infusion duration of a single dose of drug on the time course of drug concentration in the peripheral compartment of the classical two-compartment pharmacokinetic model was studied by computer simulation. The aim was to illustrate the general relationships among infusion duration T, dose, minimum effective concentration MEC at the effector (tissue) site, maximum tissue drug concentration C2,max, and the duration of effective tissue concentrations tD,tiss for those drugs where there is an equilibration delay between concentration at the effector site and plasma. Simulations of C2,max vs. T for meperidine, sulfamethoxazole, ampicillin, and metronidazole showed that, although maximum plasma concentration may decrease markedly with increasing T, C2,max decreased only slightly with increasing T. Simulations of the influence of T on the duration of effective plasma concentrations tD and tD,tiss of metronidazole showed that for a given T, tD,tiss may be greater than or less than tD, depending on the dose, and that it is possible to obtain effective concentrations in the tissue compartment even though the infusion duration is too long to achieve effective concentrations in plasma. It was found that, depending on the dose, it was possible to cause an increase in tD,tiss compared with bolus administration by increasing the infusion duration of the dose. It was also found that increasing T could cause opposite changes in tD and tD,tiss (compared with bolus administration, respectively), e.g., an increase in tD and a decrease in tD,tiss or vice versa, depending on the dose. It should thus be possible to make precise predictions of the influence of T on drug concentration at the effector site for individual drugs by incorporating effect compartment modeling into the analysis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3783449     DOI: 10.1007/bf01106710

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  13 in total

1.  Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children.

Authors:  G Levy; R Koysooko
Journal:  J Pediatr       Date:  1975-05       Impact factor: 4.406

2.  Pharmacokinetics of ampicillin in cirrhosis.

Authors:  G P Lewis; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1975-10       Impact factor: 6.875

3.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

4.  Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli.

Authors:  A W Chow; V Patten; L B Guze
Journal:  J Infect Dis       Date:  1975-02       Impact factor: 5.226

5.  Intravenous injection of gentamicin and tobramycin without impairment of hearing.

Authors:  S M Dobbs; G E Mawer
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

6.  Correlation of performance test scores with "tissue concentration" of lysergic acid diethylamide in human subjects.

Authors:  J G Wagner; G K Aghajanian; O H Bing
Journal:  Clin Pharmacol Ther       Date:  1968 Sep-Oct       Impact factor: 6.875

7.  The effect of duration of intravenous infusion on maximum and threshold blood concentration for drugs exhibiting biexponential elimination kinetics.

Authors:  D J Morgan; K Raymond
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

Review 8.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

9.  High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer.

Authors:  H R Rabin; R C Urtasun; J Partington; D Koziol; M Sharon; K Walker
Journal:  Cancer Treat Rep       Date:  1980 Oct-Nov

10.  Gentamicin intravenous infusion rate: effect on interstitial fluid concentration.

Authors:  A J Kozak; D N Gerding; L R Peterson; W H Hall
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

View more
  1 in total

1.  Influence of the rate of intravenous administration of eliprodil (SL 82.0715), a new anti-ischaemic agent, on its distribution in rat plasma and tissues.

Authors:  D Garrigou-Gadenne; J P Thenot; P L Morselli
Journal:  J Pharmacokinet Biopharm       Date:  1995-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.